Pharma

Your Unread Messages

See All

Your Article Summary

See Latest Articles

Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09

Par Pharmaceutical Companies, Inc. announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for the 100mg and 200mg strengths of tramadol ER. Ortho–McNeil sells extended–release tramadol tablets under the brand name Ultram ER. Par has been awarded 180 days of marketing exclusivity, commencing at launch, for being the first to file an ANDA containing a paragraph IV certification for the product.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

US FDA approves new indication for CRESTOR
AstraZeneca, 02/09/10

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Abbott, 02/09/10

FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
The Oncologist, 02/09/10

 See all of Drug/Product Approvals

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regions
Teva Pharmaceutical Industries, 02/09/10

Teva acquires marketing rights for oral laquinimod in the nordic and baltic regions
Active Biotech, 02/09/10

Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone
Nabi Biopharmaceuticals, 02/09/10

 See all of Marketing/Media/ROI

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Abbott, 02/09/10

Synthon announces European approvals for Raloxifene
Synthon, 02/09/10

Study Suggests Slide-On Endosheath System Provides Several Advantages Over Traditional Germicidal Immersion
Medtronic, 02/08/10

 See all of Medical Devices/Products